178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Dupilumab cuts exacerbations in late-onset asthma

Dupilumab cuts exacerbations in late-onset asthma

(HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a study presented at

Dupilumab cuts exacerbations in late-onset asthma

(HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, according to a study presented at
CrAss viral content: When it's in your gut, it might be good for your health

CrAss viral content: When it's in your gut, it might be good for your health

by Osaka UniversityFig.1 Schematic illustration of the study design. Credit: Yoshihiko Tomofuji et al.,Annals of the Rheumatic DiseasesAutoimmune diseases are conditions in which the immune

CrAss viral content: When it's in your gut, it might be good for your health

by Osaka UniversityFig.1 Schematic illustration of the study design. Credit: Yoshihiko Tomofuji et al.,Annals of the Rheumatic DiseasesAutoimmune diseases are conditions in which the immune
T-cell molecule could be the key to more effective virus and cancer treatments

T-cell molecule could be the key to more effective virus and cancer treatments

by Julia Short,Cardiff UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDResearchers at Cardiff Univer

T-cell molecule could be the key to more effective virus and cancer treatments

by Julia Short,Cardiff UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDResearchers at Cardiff Univer
Experiments in infant mice suggest new way to prevent spread of flu in people

Experiments in infant mice suggest new way to prevent spread of flu in people

JANUARY 11, 2024byNYU Langone HealthCredit: Andrea Piacquadio from PexelsScientists have long known that some viruses and bacteria begin infections by latching first onto sugar molecules on the

Experiments in infant mice suggest new way to prevent spread of flu in people

JANUARY 11, 2024byNYU Langone HealthCredit: Andrea Piacquadio from PexelsScientists have long known that some viruses and bacteria begin infections by latching first onto sugar molecules on the
Gender, high DAS28-P index predictive of pain in early RA

Gender, high DAS28-P index predictive of pain in early RA

(HealthDay) -- For patients with rheumatoid arthritis (RA), female gender and having a high proportion of disease activity score (DAS28) attributable to patient-reported components (joint tenderness a

Gender, high DAS28-P index predictive of pain in early RA

(HealthDay) -- For patients with rheumatoid arthritis (RA), female gender and having a high proportion of disease activity score (DAS28) attributable to patient-reported components (joint tenderness a
Hope for patients with rare Sjögren's syndrome

Hope for patients with rare Sjögren's syndrome

by Newcastle UniversityProfessor Fai Ng. Credit: Newcastle UniversityA new study has shed light on a debilitating autoimmune condition by identifying a number of subtypes of the disease which cou

Hope for patients with rare Sjögren's syndrome

by Newcastle UniversityProfessor Fai Ng. Credit: Newcastle UniversityA new study has shed light on a debilitating autoimmune condition by identifying a number of subtypes of the disease which cou
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

by La Jolla Institute for ImmunologyA multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease se

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

by La Jolla Institute for ImmunologyA multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease se
COVID-19, MIS-C and Kawasaki disease share same immune response

COVID-19, MIS-C and Kawasaki disease share same immune response

by University of California - San DiegoUC San Diego researchers summarize the similarities and differences between COVID-19, MIS-C and Kawasaki disease, three conditions unified by the same immun

COVID-19, MIS-C and Kawasaki disease share same immune response

by University of California - San DiegoUC San Diego researchers summarize the similarities and differences between COVID-19, MIS-C and Kawasaki disease, three conditions unified by the same immun
Study suggests staying current with COVID-19 vaccinations helps combat emerging variants

Study suggests staying current with COVID-19 vaccinations helps combat emerging variants

by Erik Robinson,Oregon Health & Science UniversityA COVID-19 vaccine is prepped at an OHSU clinic. New research from OHSU reveals a strong immune response to an updated vaccine in the fall

Study suggests staying current with COVID-19 vaccinations helps combat emerging variants

by Erik Robinson,Oregon Health & Science UniversityA COVID-19 vaccine is prepped at an OHSU clinic. New research from OHSU reveals a strong immune response to an updated vaccine in the fall
Long-term rituximab safe for patients with wegener's

Long-term rituximab safe for patients with wegener's

Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener&#3

Long-term rituximab safe for patients with wegener's

Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener&#3
Upadacitinib beats placebo for psoriatic arthritis

Upadacitinib beats placebo for psoriatic arthritis

For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of theNew England J

Upadacitinib beats placebo for psoriatic arthritis

For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of theNew England J
Survival improving after hip and knee replacement

Survival improving after hip and knee replacement

(HealthDay)—Short-term survival after elective total hip (THR) and total knee replacement (TKR) has greatly improved since the early 1990s, even though comorbidities have increased, according to a stu

Survival improving after hip and knee replacement

(HealthDay)—Short-term survival after elective total hip (THR) and total knee replacement (TKR) has greatly improved since the early 1990s, even though comorbidities have increased, according to a stu